O Fursa, W Bannister, B Neesgaard, D Podlekareva, J Kowalska, T Benfield, J Gerstoft, J Reekie, L D Rasmussen, I Aho, G Guaraldi, T Staub, J M Miro, J M Laporte, D Elbirt, T Trofimova, D Sedlacek, R Matulionyte, C Oprea, E Bernasconi, V Hadžiosmanović, A Mocroft, L Peters
BACKGROUND: Although people with HIV might be at risk of severe outcomes from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; coronavirus 2019 [COVID-19]), regional and temporal differences in SARS-CoV-2 testing in people with HIV across Europe have not been previously described. METHODS: We described the proportions of testing, positive test results, and hospitalizations due to COVID-19 between 1 January 2020 and 31 December 2021 in the EuroSIDA cohort and the factors associated with being tested for SARS-CoV-2 and with ever testing positive...
March 3, 2024: HIV Medicine